Literature DB >> 19498413

Understanding of nicotinic acetylcholine receptors.

Jie Wu1.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19498413      PMCID： PMC4002371          DOI： 10.1038/aps.2009.89

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN： 1671-4083            Impact factor:   6.150


× No keyword cloud information.
  22 in total

Review 1.  Neuronal nicotinic acetylcholine receptors: from the genetic analysis to neurological diseases.

Authors:  O K Steinlein; D Bertrand
Journal:  Biochem Pharmacol       Date:  2008-07-19       Impact factor: 5.858

Review 2.  Synaptic plasticity within midbrain dopamine centers contributes to nicotine addiction.

Authors:  Andon N Placzek; John A Dani
Journal:  Nebr Symp Motiv       Date:  2009

Review 3.  New findings on nicotine addiction and treatment.

Authors:  Jed E Rose
Journal:  Nebr Symp Motiv       Date:  2009

4.  X-ray structure of a pentameric ligand-gated ion channel in an apparently open conformation.

Authors:  Nicolas Bocquet; Hugues Nury; Marc Baaden; Chantal Le Poupon; Jean-Pierre Changeux; Marc Delarue; Pierre-Jean Corringer
Journal:  Nature       Date:  2008-11-05       Impact factor: 49.962

Review 5.  Multiple brain pathways and receptors underlying tobacco addiction.

Authors:  Jed E Rose
Journal:  Biochem Pharmacol       Date:  2007-08-03       Impact factor: 5.858

6.  The simulation of addiction: pharmacological and neurocomputational models of drug self-administration.

Authors:  Serge H Ahmed; Georgiy Bobashev; Boris S Gutkin
Journal:  Drug Alcohol Depend       Date:  2007-10-08       Impact factor: 4.492

Review 7.  Mammalian nicotinic acetylcholine receptors: from structure to function.

Authors:  Edson X Albuquerque; Edna F R Pereira; Manickavasagom Alkondon; Scott W Rogers
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

Review 8.  Molecular mechanisms underlying the motivational effects of nicotine.

Authors:  Darlene H Brunzell; Marina R Picciotto
Journal:  Nebr Symp Motiv       Date:  2009

Review 9.  Diversity of vertebrate nicotinic acetylcholine receptors.

Authors:  Neil S Millar; Cecilia Gotti
Journal:  Neuropharmacology       Date:  2008-08-05       Impact factor: 5.250

Review 10.  Structural answers and persistent questions about how nicotinic receptors work.

Authors:  Gregg B Wells
Journal:  Front Biosci       Date:  2008-05-01
View more
  7 in total

Review 1.  Biological determinants impact the neurovascular toxicity of nicotine and tobacco smoke: A pharmacokinetic and pharmacodynamics perspective.

Authors:  Sabrina Rahman Archie; Sejal Sharma; Elizabeth Burks; Thomas Abbruscato
Journal:  Neurotoxicology       Date:  2022-02-09       Impact factor: 4.294

2.  α7 nicotinic acetylcholine receptor-mediated neuroprotection against dopaminergic neuron loss in an MPTP mouse model via inhibition of astrocyte activation.

Authors:  Yuan Liu; Jun Hu; Jie Wu; Chenlei Zhu; Yujian Hui; Yaping Han; Zuhu Huang; Kevin Ellsworth; Weimin Fan
Journal:  J Neuroinflammation       Date:  2012-05-24       Impact factor: 8.322

3.  Nicotinic Receptor Abnormalities in the Cerebellar Cortex of Sudden Unexplained Fetal and Infant Death Victims-Possible Correlation With Maternal Smoking.

Authors:  Anna M Lavezzi; Stefano Ferrero; Luca Roncati; Francesco Piscioli; Luigi Matturri; Teresa Pusiol
Journal:  ASN Neuro       Date:  2017 Jul-Aug       Impact factor: 4.146

4.  Trends in neonicotinoid pesticide residues in food and water in the United States, 1999-2015.

Authors:  Hillary A Craddock; Dina Huang; Paul C Turner; Lesliam Quirós-Alcalá; Devon C Payne-Sturges
Journal:  Environ Health       Date:  2019-01-11       Impact factor: 5.984

Review 5.  Racial Health Disparity and COVID-19.

Authors:  Santosh Kumar; Prashant Kumar; Sunitha Kodidela; Benjamin Duhart; Alina Cernasev; Anantha Nookala; Asit Kumar; Udai P Singh; John Bissler
Journal:  J Neuroimmune Pharmacol       Date:  2021-09-09       Impact factor: 4.147

6.  Pharmacogenetic study of seven polymorphisms in three nicotinic acetylcholine receptor subunits in smoking-cessation therapies.

Authors:  Giulia Pintarelli; Antonella Galvan; Paolo Pozzi; Sara Noci; Giovanna Pasetti; Francesca Sala; Ugo Pastorino; Roberto Boffi; Francesca Colombo
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

7.  The Natural Compound Dehydrocrenatidine Attenuates Nicotine-Induced Stemness and Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma by Regulating a7nAChR-Jak2 Signaling Pathways.

Authors:  Ching-Li Li; Chien-Che Wang; Hsin-Te Pai; Stan-Ley Tu; Pin-Yuan Hou; Chien-Yu Huang; Ming-Te Huang; Yu-Jia Chang
Journal:  Dis Markers       Date:  2022-01-24       Impact factor: 3.434
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.